$4.70
Today
as of Sep 4, 16:47 ET
Last 30 days
Recent Press Releases & News
Cytek® Biosciences Highlights the Expanding Role of Spectral Flow Cytometry in Clinical Research at ESCCA and ICCS
Cytek Biosciences to Participate in Upcoming Investor Conferences
Jury Finds in Cytek’s Favor on Three of Four Asserted Claims; Company to Challenge Remaining Finding
Overview
52-week range
$3.28
$6.18
49% of range
Avg surprise (last 3)
-39.5%
Avg reaction (last 2)
+0.6%
50% positive
Latest IV / EM
742%
EM ±123.9% · $5 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $-0.15 | $-0.11 | -36.4% | -66.7% | -0.4% | earnings |
| Wed Aug 6, 2025 | Jun/2025 | $-0.04 | $-0.07 | +42.9% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.09 | $-0.04 | -125.0% | — | +1.6% | earnings |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $48M | $44M | — | $52M | $46M | $41M | — | $52M |
| Cost of revenue | $20M | $23M | — | $25M | $22M | $21M | — | $22M |
| Gross profit | $28M | $21M | — | $28M | $24M | $20M | — | $29M |
| Operating income | $-11M | $-18M | — | $-9M | $-11M | $-15M | — | $-4M |
| Net income | $-12M | $-19M | — | $-5M | $-6M | $-11M | — | $941,000 |
| EPS (diluted) | — | — | — | — | — | — | — | — |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $74M | $66M | $91M | $93M | $75M | $95M | $99M | $162M |
| Inventory | $52M | $50M | $48M | $52M | $49M | $45M | $44M | $47M |
| Total current assets | $378M | $379M | $392M | $388M | $383M | $381M | $396M | $390M |
| Total assets | $447M | $449M | $462M | $495M | $493M | $483M | $500M | $491M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $125M | $121M | $120M | $116M | $116M | $103M | $104M | $106M |
| Total equity | $322M | $328M | $342M | $379M | $378M | $380M | $396M | $385M |